Home/Filings/4/0001209191-17-038262
4//SEC Filing

Epizyme, Inc. 4

Accession 0001209191-17-038262

CIK 0001571498operating

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 1:48 PM ET

Size

8.6 KB

Accession

0001209191-17-038262

Insider Transaction Report

Form 4
Period: 2017-06-06
Copeland Robert A
EVP and CSO10% Owner
Transactions
  • Sale

    Commons Stock, par value $0.0001

    2017-06-06$13.45/sh2,500$33,62531,538 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-06-062,50036,050 total
    Exercise: $3.54Exp: 2023-01-24Common Stock (2,500 underlying)
  • Exercise/Conversion

    Commons Stock, par value $0.0001

    2017-06-06$3.54/sh+2,500$8,85034,038 total
Footnotes (2)
  • [F1]The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]This option is fully vested.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001571498

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 1:48 PM ET
Size
8.6 KB